The World Health Organization wants to tackle inequity and bureaucracy relating to clinical trials. Will its latest guidance make a difference? Anna Volkmer reports During the covid-19 pandemic the UK ...

Moderna (MRNA), once a pandemic-era darling, has seen its stock plummet 65% over the past year, battered by fading vaccine demand and pipeline ...

Yousif Capital Management LLC lifted its stake in shares of Moderna, Inc. (NASDAQ:MRNA – Free Report) by 3.9% during the ...

RFK Jr.’s views on vaccine safety have sparked debate, with some experts saying that his comments are misleading.

The pandemic death total stands at 1,252 as of February 1, 2025 (the most recent data available). The 5 reported deaths last ...

(CN) — A federal judge has temporarily blocked an expected $4 billion slash to funding for biomedical research after a group ...

The lawsuit, filed in federal court in Boston, challenges the Trump administration, the Department of Health and Human Services and the National Institutes of Health over efforts to reduce funding ...

(CN) — A coalition of 22 state attorneys general is taking aim at a Trump administration policy that would slash funding for ...

Janney Montgomery Scott LLC lowered its holdings in Moderna, Inc. (NASDAQ:MRNA – Free Report) by 21.0% in the fourth quarter, ...

O n Friday, February 7, a hearing took place in the Montana state legislature on a bill that would ban the use of mRNA vaccines in humans. The bill was sponsored by State Representative Greg Kmetz ...

Moderna Inc. dropped its share prices by 17 percent last week to finish at $32.6 from the $39.42 registered on January 31 as ...

To come up with last week’s worst performers, we considered only the stocks with at least $2 billion in market capitalization ...